Hinge Health, Inc.
Hinge Health, Inc. (HNGE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hnge · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Hinge Health, Inc. (HNGE) measures how much investors pay for each dollar of the company's trailing earnings. HNGE's current PE ratio of N/A is calculated by dividing its stock price of $63.66 by its TTM earnings per share of -$6.49.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2023 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hinge Health, Inc.You HNGE | $4.9B | N/A | — | -$6.49 |
 Akero Therapeutics, Inc. AKRO | $4.5B | N/A | — | -$3.75 |
 Crinetics Pharmaceuticals, Inc. CRNX | $3.5B | N/A | — | -$4.95 |
 Dyne Therapeutics, Inc. DYN | $2.8B | N/A | — | -$3.47 |
 Immunovant, Inc. IMVT | $6.4B | N/A | — | -$2.77 |
 Indivior Pharmaceuticals Inc INDV | $4.7B | 21.36x | +5.2% | $1.68 |
 Lantheus Holdings, Inc. LNTH | $6.6B | 19.23x | -5.2% | $3.46 |
Industry Average 2 peers with valid PE | — | 20.29x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-6.67 | — | |
2024-12-31 FY2024 | — | $-0.15 | — | |
2023-12-31 FY2023 | — | $-1.39 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hinge Health, Inc. (HNGE) measures how much investors pay for each dollar of the company's trailing earnings. HNGE's current PE ratio of N/A is calculated by dividing its stock price of $63.66 by its TTM earnings per share of -$6.49.
Frequently asked questions
HNGE pe ratio · 6 questionsHNGE's current PE ratio is N/A as of 2026-06-08, based on a stock price of $63.66 and TTM EPS of -$6.49. Data sourced from Financial Modeling Prep via HNGE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hinge Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08